YZYing Zhang

Ying Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Zhang has a total of 173 co-authors. Here are the top co-authors by number of shared publications:

  • Qing Liu

    Department of Pain The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University Luzhou City China

    15 shared publications
  • Yan Liu

    The Department of Anesthesiology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China

    7 shared publications
  • Qun Li

    Luzhou Key Laboratory of Research for Integrative on Pain and Perioperative Organ Protection & Department of Anesthesiology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, China

    6 shared publications
  • Qing Liu

    The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China

    5 shared publications
  • Qiu-Xia Xiao

    Department of Anesthesiology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, 646000 Luzhou, Sichuan, China

    5 shared publications
  • Rui Deng

    Department of Anesthesiology, People’s Hospital of Deyang City, Deyang, China

    5 shared publications

Latest Publications

  • RNase H-recycling-assisted dual-channel graphene oxide-aptamer biosensor for rapid detection of CRP and LDL in patients with coronary artery disease

    by Tian-Tian Wang, Shao-Xuan Zhang, Yi-Hua Ma, Zhong-Jue Qiu, Qun Li, Hong-Na Su, Yu-Hong Liang, Zhi-Feng Zhang, Hui Huang, Jing-Rong Wang, et al.

  • Open Access

    Impact of circadian rhythm change on postoperative delirium in elderly patients undergoing lower extremity orthopedic surgery: a propensity score-matched prospective cohort study

    by Feng Xiao, Qing Zhong, Hui Liu, Zehao Liu, Funing Liu, Yunqiong Zhang, Ying Zhang

    Background: Postoperative delirium (POD) is a common and clinically significant complication associated with numerous adverse outcomes, including prolonged hospitalization, functional decline, and increased mortality. Older adults undergoing lower extremity orthopedic surgery constitute a particularly high-risk population for POD. Previous studies have reported an incidence of POD as high as 34.2% among elderly patients undergoing hip surgery receiving general anesthesia. Although some research has examined the influence of circadian rhythm on cognitive function, the comparative impact of perioperative circadian rhythm change on POD incidence in elderly patients undergoing lower extremity orthopedic procedures remains unexplored. This study therefore undertakes a prospective cohort design to investigate the association between perioperative circadian rhythm change and the risk of POD in this vulnerable patient group. Methods: Eligible participants were patients aged ≥60 years, of any gender, with American Society of Anesthesiologists (ASA) physical status classification I–III, who underwent elective lower extremity orthopedic surgery under general anesthesia at our institution. Patients were categorized into two groups based on perioperative stability of circadian rhythm: the circadian rhythm change group (Group C) and the no circadian rhythm change group (Group NC). To minimize baseline imbalances between groups, 1:1 propensity score matching (PSM) was performed using a nearest-neighbor algorithm with a caliper width of 0.05. Following matching, multivariable logistic regression was used to assess the association between circadian rhythm change and the incidence of postoperative delirium (POD), while linear regression was employed to evaluate its effect on length of hospital stay. Subgroup analyses were further conducted to explore potential effect modification and to address residual confounding within the matched cohort. Results: A total of 277 patients met the inclusion criteria and were included in the analysis between August 2024 and January 2025. Following propensity score matching, POD occurred in 37 patients (34.58%) in the Group C and 20 patients (18.69%) in the Group NC. After identifying independent variables potentially associated with POD and adjusting for confounders using binary logistic regression, we found that perioperative circadian rhythm change was independently associated with a higher risk of POD (OR = 2.26; p = 0.02). Additionally, multiple linear regression analysis revealed that circadian rhythm change was significantly associated with a longer hospital length of stay. Subgroup analyses suggested a stronger association between circadian rhythm change and POD in patients p = 0.001) and those with better postoperative sleep quality (PSQI ≤8; OR = 6.09, p < 0.001), though no interaction remained significant after Bonferroni correction. Conclusion: Perioperative circadian rhythm change—indexed by MEQ-SA score shifts—is an independent risk factor for postoperative delirium and prolonged hospitalization in older adults undergoing lower extremity orthopedic surgery, highlighting circadian stability as a novel, modifiable target for perioperative neuroprotection.

  • Top Cited Papers

    Gastrodin Ameliorates Pain-Depression Comorbidity through SIRT3-Dependent Alleviation of Oxidative Stress and Promotion of Mitochondrial Biogenesis

    by Feiran Zhou, Yijian Luo, Yan Liu, Lin Luo, Ping Jiang, Qing Liu, Ying Zhang

    Neuropathic pain (NP) and depression frequently co-occur, creating a complex clinical challenge with limited therapeutic options due to poorly understood shared mechanisms. Our preliminary screening identified the mitochondrial deacetylase SIRT3 as a potential key regulator of this comorbidity. Building on this finding, we hypothesized that Gastrodin, a natural compound with documented neuroprotective properties, exerts its therapeutic effects by targeting SIRT3. This study was therefore designed to investigate whether Gastrodin alleviates NP-depression comorbidity through a SIRT3-dependent mechanism. A rat model of NP-depression comorbidity was established by combining spared sciatic nerve injury (SNI) with chronic unpredictable mild stress (CUMS). Behavioral tests were conducted to assess mechanical allodynia, thermal hyperalgesia, and depression-like behaviors. Molecular mechanisms were evaluated using Western blot, ELISA, qPCR, and transmission electron microscopy. The specific role of SIRT3 was confirmed using the inhibitor 3-TYP in vivo and siRNA in vitro. Gastrodin administration (200/300 mg/kg) significantly ameliorated both pain hypersensitivity and depression-like behaviors in the comorbidity model. Mechanistically, Gastrodin upregulated SIRT3 expression and enhanced its deacetylase activity in the hippocampus, as evidenced by reduced acetylation of SOD2. This led to attenuated neuroinflammation (TNF-α, IL-1β, IL-6) and oxidative stress (MDA, ROS). Furthermore, Gastrodin improved mitochondrial ultrastructure and promoted mitochondrial biogenesis via the PGC-1α/TFAM pathway in astrocytes. Critically, all therapeutic benefits of Gastrodin were abolished upon SIRT3 inhibition. Gastrodin exerts dual therapeutic effects on NP-depression comorbidity by activating the SIRT3 pathway, thereby rescuing mitochondrial function in hippocampal astrocytes. These findings identify Gastrodin as a promising candidate for treating pain-depression comorbidity and underscore SIRT3 as a critical therapeutic target.


  • Open Access

    Astragaloside IV Attenuates Myocardial Ischemia‐Reperfusion Injury via Suppression of the NOX4/ROS Axis: Mechanistic Insights From In Vivo and In Vitro Models

    by Xiao Liu, Zongyan Li, Yan Liu, Tianmei Li, Yao Huang, Qing Liu, Ying Zhang

    Myocardial ischemia‐reperfusion injury (MIRI) stands as a critical determinant undermining the therapeutic efficacy of revascularization procedures in treating myocardial infarction cases. Among the various injury mechanisms discussed herein, oxidative stress plays a crucial role, with nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) identified as a key enzyme responsible for orchestrating the production of reactive oxygen species (ROS). Astragaloside IV (AS‐IV), an extract derived from Astragalus membranaceus , a traditional Chinese medicinal herb, exhibits antioxidative stress properties. In this study, we aimed to investigate the efficacy of AS‐IV in mitigating MIRI and to elucidate the underlying regulatory mechanisms. We established a model of MIRI in Sprague–Dawley (SD) rats and employed an oxygen‐dependent glycan deprivation/reoxygenation (OGD/R) model using the rat myocardial H9C2 cell line. AS‐IV treatment significantly mitigated cardiac functional injury, pathological damage, and the infarct area resulting from ischemia‐reperfusion (I/R). Furthermore, AS‐IV administration effectively reduced oxidative stress levels both in vitro and in vivo. It has been demonstrated that AS‐IV modulates ROS production and alleviates oxidative stress associated with I/R injury by inhibiting NOX4 expression. Therefore, AS‐IV exhibits considerable potential as a therapeutic intervention for the management of myocardial I/R.


  • Open Access

    A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain

    by Cheng Zhixiang, Lu Yan, Liu Xianguo, Xia Lingjie, Huang Dong, Song Tao, Liang Lishuang, Zhang Ying, Liu Tanghua, Wang Lin, et al.

    Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.


  • Open Access

    Correction: Endoglin alleviates neuropathic pain by protecting the blood–spinal cord barrier through the TGF-β/Smad2 signaling pathway

    by SiJing Liao, Fei-Ran Zhou, Qun Li, Tao Jin, Gui-Fang Xiang, Xin Wang, Yan Liu, Hq Zhu, Qing Liu, Yuexin Liu, et al.

    A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. Instructions: ● Please read through all the templates before choosing ● Pick the most relevant text template(s) from the following page and delete all others. ● Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ● Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ● Submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Correction: Endoglin alleviates neuropathic pain by protecting the blood–spinal cord barrier through the TGF-β/Smad2 signaling pathway Correction on: Liao S, Zhou F-R, Li Q, Jin T, Xiang G-F, Wang X, Liu Y, Zhu H, Liu Q, Liu Y and Zhang Y (2025) Endoglin alleviates neuropathic pain by protecting the blood–spinal cord barrier through the TGF-β/Smad2 signaling pathway. Front. Mol.Neurosci.18:1603619.doi:10.3389/fnmol.2025.1603619 Author affiliation Affiliation [1、Traditional Chinese Medicine Hospital of Meishan, Meishan, China 2、 The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China 3、Hejiang Traditional Chinese Medicine Hospital, Luzhou, China] was erroneously given as [1、Traditional Chinese Medicine Hospital of Meishan, Meisham, China 2、Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China 3、Hejiang County Traditional Chinese Medicine Hospital, Luzhou, China].. The original version of this article has been updated.

  • Open Access

    Endoglin alleviates neuropathic pain by protecting the blood–spinal cord barrier through the TGF-β/Smad2 signaling pathway

    by SiJing Liao, Fei-Ran Zhou, Qun Li, Tao Jin, Gui-Fang Xiang, Xin Wang, Yan Liu, Hq Zhu, Qing Liu, Yuexin Liu, et al.

    Introduction: Central neuroinflammation is pivotal in neuropathic pain pathogenesis, with blood-spinal cord barrier (BSCB) dysfunction recognized as a trigger for neuroinflammation and pain, though molecular mechanisms remain poorly understood.Methods: Through comparative clinical studies measuring serum endoglin in postherpetic neuralgia (PHN) patients versus healthy controls, and animal investigations using spared nerve injury (SNI) rat models with recombinant endoglin intervention, we assessed mechanical/thermal hyperalgesia, microglial activation, inflammatory cytokines, BSCB permeability, and TGF-βRI/Smad2/NR2B phosphorylation.Results: PHN patients exhibited lower serum endoglin versus controls; SNI rats showed reduced spinal endoglin compared to sham controls. Recombinant endoglin alleviated hyperalgesia while reversing microglial activation, inflammation, BSCB impairment, and NR2B phosphorylation. SNI decreased spinal TGF-βRI expression and Smad2 phosphorylation.Discussion: These findings demonstrate that endoglin reduction disrupts BSCB integrity via TGF-β/Smad2 pathway inhibition in endothelial cells, driving microglial activation, neuroinflammation, and NR2B phosphorylation, thereby elucidating a key pain mechanism and identifying endoglin as a therapeutic target.


  • Open Access

    Ventilation Difficulty During Tracheostomy After Esophageal Cancer Surgery: A Case Report

    by Xi Wang, Mingjie Li, Qing Liu, Ying Zhang

    We report a case of a 67‐year‐old male patient who experienced difficulty in ventilation during a tracheotomy due to active oral bleeding following esophageal cancer surgery. In this article, we aimed to explore the causes, potential risks, and management experiences of ventilation difficulties during tracheotomy after esophageal cancer surgery.

  • Open Access

    The primary somatosensory sensory cortex-basolateral amygdala pathway contributes to comorbid depression in spared nerve injury-induced neuropathic pain

    by Guo Chen, Min Luo, Wentao Chen, Yu Zhang, Zuchao Gu, Miaomiao Xu, Ying Zhang, Jiang Bian

    Comorbid depression in chronic pain is a prevalent health problem, yet the underlying neural mechanisms remain largely unexplored. This study identified a dedicated neural circuit connecting the hind limb region of the primary somatosensory cortex (S1HL) to the basolateral amygdala (BLA) that mediated neuropathic pain-induced depression. We demonstrated that depressive-like behaviors in the chronic phase of a mouse neuropathic pain model were associated with heightened activity in the S1HL and BLA. Using viral tracing and RNAscope in situ hybridization, we characterized the circuit architecture of S1HL glutamatergic projections to BLA cholecystokinin (CCK) neurons (S1HLGlu → BLACCK). In vivo fiber photometry calcium imaging revealed that both the S1HL BLA-projecting afferents and the BLA S1HL-innervating neurons exhibited hyperactivity in neuropathic pain-induced depressive states. Chemogenetic inhibition of the S1HL → BLA circuit could block neuropathic pain-induced depressive-like behaviors. In addition, specific knockdown of CCK expression in BLA S1HL-innervating neurons alleviated these depressive-like behaviors. Our findings demonstrated that the cortical-amygdala circuit S1HLGlu → BLACCK drove the transition from chronic pain to depression, thus suggesting a potential neural circuit basis for treating chronic pain-related depressive disorders.